SGS Life Sciences, a division of SGS Belgium NV
11
0
0
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
36%
4 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
A Phase 1 Study to Investigate Safety, Tolerability, and Pharmacokinetics of CK-0045 in Healthy Participants and Otherwise Healthy Participants With Obesity
Role: collaborator
Phase 1 Study of ELX-02 in Healthy Adults
Role: collaborator
Cold Challenge With C21 in RP
Role: collaborator
Study in Blood Stage Malaria Infection After DVI of Cryopreserved P. Falciparum (NF54 Strain) Sporozoites
Role: collaborator
Safety, Tolerability and Chemoprotective Activity of P218 in PfSPZ Challenge Model
Role: collaborator
Phase 1 Study of ELX-02 in Healthy Adult Subjects
Role: collaborator
Phase 1 Study of ATR-002
Role: collaborator
A Study to Determine the Safety and Attack Rate of the Seasonal Flu in Healthy Volunteers
Role: lead
Mass Balance Study of 14C-labelled GFT505 in Healthy Volunteers
Role: collaborator
Effect of Thiamphenicol on EAAT2 and Other Biomarkers From Nasal Biopsied Tissue
Role: collaborator
Safety, Preliminary Pharmacokinetics and Bronchodilator Properties of V0162
Role: collaborator
All 11 trials loaded